Annual report pursuant to Section 13 and 15(d)

Net Loss Per Share - Schedule of Antidilutive Securities (Details)

v3.23.1
Net Loss Per Share - Schedule of Antidilutive Securities (Details) - shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Virgin Orbit options outstanding    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 12,038,930 10,704,645
Virgin Orbit restricted stock units outstanding    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 3,837,290 0
Private Placement Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 6,742,927 6,742,927
Public warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 7,651,891 7,651,891
Third-Party PIPE Investor warrant    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 500,000 500,000
Shares related to Convertible Notes    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 23,513,514 0
Sponsor Earnback Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 1,015,190